Neurology Department, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Neurology Department, Elias University Emergency Hospital, 011461 Bucharest, Romania.
Medicina (Kaunas). 2022 Mar 3;58(3):377. doi: 10.3390/medicina58030377.
In this critical review, we explore the potential use of MRI measurements as prognostic biomarkers in multiple sclerosis (MS) patients, for both conventional measurements and more novel techniques such as magnetization transfer, diffusion tensor, and proton spectroscopy MRI. All authors individually and comprehensively reviewed each of the aspects listed below in PubMed, Medline, and Google Scholar. There are numerous MRI metrics that have been proven by clinical studies to hold important prognostic value for MS patients, most of which can be readily obtained from standard 1.5T MRI scans. While some of these parameters have passed the test of time and seem to be associated with a reliable predictive power, some are still better interpreted with caution. We hope this will serve as a reminder of how vast a resource we have on our hands in this versatile tool-it is up to us to make use of it.
在这篇评论中,我们探讨了 MRI 测量作为多发性硬化症(MS)患者预后生物标志物的潜在用途,包括传统测量方法和磁化转移、扩散张量和质子波谱 MRI 等新技术。所有作者分别在 PubMed、Medline 和 Google Scholar 上全面审查了以下列出的各个方面。有许多 MRI 指标已被临床研究证明对 MS 患者具有重要的预后价值,其中大多数指标可以从标准的 1.5T MRI 扫描中获得。虽然其中一些参数已经经受住了时间的考验,并且似乎与可靠的预测能力相关,但有些参数仍需要谨慎解释。我们希望这将提醒我们,在这个多功能工具中,我们拥有多么丰富的资源——这取决于我们是否利用它。